Dow Up 0.19% Nasdaq Up 0.56%

XOMA Corporation (XOMA)

-NasdaqGM
4.54 Up 0.43(10.33%) 4:00PM EST
|After Hours : 4.65 Up 0.11 (2.42%) 5:52PM EST
Prev Close:4.12
Open:4.20
Bid:4.60 x 500
Ask:4.61 x 500
1y Target Est:8.86
Beta:4.4
Next Earnings Date:N/A
Day's Range:4.16 - 4.60
52wk Range:3.42 - 9.57
Volume:3,687,909
Avg Vol (3m):1,321,310
Market Cap:487.57M
P/E (ttm):N/A
EPS (ttm):-1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMAUp 10.33%487.57M
NVSDown 0.48%230.43B
REGNDown 2.23%40.92B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.46
Quarterly EPS Est (Dec-14) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback